PCPeggy Charbonnier

Peggy Charbonnier

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Peggy Charbonnier has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Copper transport across cell membranes by calix[4]arene-based cationophores leading to potent biological activity

    by Nathan Renier, Gianluca Weyckmans Mele, Pierre Lelièvre, Mélanie Boeckstaens, Roy Lavendomme, Akin Aydogan, Yannick Dussein, Peggy Charbonnier, Laurens Puillet Anselme, Benoit Chovelon, et al.

    Lipid bilayers are impermeable to ions, including copper cations. Copper is an essential trace element for life, present in the active site of various enzymes, whereas free copper is detrimental inside cells. Copper homeostasis is thus finely controlled, involving Cu(I) transporting membrane proteins Ctr1 and ATP7A/B. Disruption of copper homeostasis has been reported as a potential anti-cancer strategy. With this objective, we have developed a series of lipophilic compounds with two copper coordinating (benz)imidazole groups that are able to function as ionophores, transporting copper cations across membranes. This was firstly demonstrated in liposomes with a Cu(I) sensitive fluorescent probe encapsulated. Secondly, five of these compounds were shown to restore the growth of yeast cells that had Ctr1 deleted, suggesting that these ionophores were able to transport copper into yeast cells. Thirdly, cytotoxicity studies in hepatocarcinoma cells highlighted the crucial role of the lipophilicity of Cu ionophores for their activity in cells. The impact of one of the most active compounds, named Cuphoralix, was further studied, showing no increase of intracellular Cu levels of the hepatocytes, but clear indications of metallic stress. Synchrotron X-ray fluorescence studies were then employed to study the effect of Cuphoralix on the subcellular copper distribution, revealing a redistribution of copper from vesicles to the cytosol. This explains the potent cytotoxicity of this novel class of copper ionophores, warranting further studies of their anti-cancer effects.

  • Open Access

    ATP7B-Deficient Hepatocytes Reveal the Importance of Protein Misfolding Induced at Low Copper Concentration

    by Peggy Charbonnier, Benoît Chovelon, Corinne Ravelet, Tuan Dung Ngo, Mireille Chevallet, Aurélien Deniaud

    Copper is a transition metal essential for human life. Its homeostasis is regulated in the liver, which delivers copper to the whole body and excretes its excess outside the organism in the feces through the bile. These functions are regulated within hepatocytes, and the ATP7B copper transporter is central to making the switch between copper use and excretion. In Wilson disease, the gene coding for ATP7B is mutated, leading to copper overload, firstly, in the liver and the brain. To better understand the role of ATP7B in hepatocytes and to provide a smart tool for the development of novel therapies against Wilson disease, we used the CrispR/Cas9 tool to generate hepatocyte cell lines with the abolished expression of ATP7B. These cell lines revealed that ATP7B plays a major role at low copper concentrations starting in the micromolar range. Moreover, metal stress markers are induced at lower copper concentrations compared to parental cells, while redox stress remains not activated. As shown recently, the main drawback induced by copper exposure is protein unfolding that is drastically exacerbated in ATP7B-deficient cells. Our data enabled us to propose that the zinc finger domain of DNAJ-A1 would serve as a sensor of Cu stress. Therefore, these Wilson-like hepatocytes are of high interest to explore in more detail the role of ATP7B.


  • Open Access

    Copper-Associated Oxidative Stress Contributes to Cellular Inflammatory Responses in Cystic Fibrosis

    by Amal Kouadri, Johanna Cormenier, Kevin Gemy, Laurence Macari, Peggy Charbonnier, Pierre Richaud, Isabelle Michaud-Soret, Nadia Alfaidy, Mohamed Benharouga

    Cystic fibrosis (CF) is caused by mutations in the gene encoding the CF Transmembrane Conductance Regulator (CFTR), an apical chloride channel. An early inflammation (EI) in the lung of CF patients occurring in the absence of any bacterial infection has been reported. This EI has been proposed to be associated with oxidative stress (OX-S), generated by deregulations of the oxidant/antioxidant status. Recently, we demonstrated that copper (Cu), an essential trace element, mediates OX-S in bronchial cells. However, the role of this element in the development of CF-EI, in association with OX-S, has never been investigated. Using healthy (16HBE14o-; HBE), CF (CFBE14o-; CFBE), and corrected-wild type CFTR CF (CFBE-wt) bronchial cells, we characterized the inflammation and OX-S profiles in relation to the copper status and CFTR expression and function. We demonstrated that CFBE cells exhibited a CFTR-independent intrinsic inflammation. These cells also exhibited an alteration in mitochondria, UPR (Unfolded Protein Response), catalase, Cu/Zn- and Mn-SOD activities, and an increase in the intracellular content of iron, zinc, and Cu. The increase in Cu concentration was associated with OX-S and inflammatory responses. These data identify cellular Cu as a key factor in the generation of CF-associated OX-S and opens new areas of investigation to better understand CF-associated EI.


  • Open Access

    Visualization of silver nanoparticle intracellular trafficking revealed nuclear translocation of silver ions leading to nuclear receptor impairment

    by Vanessa Tardillo Suárez, Elizaveta Karepina, Mireille Chevallet, Benoit Gallet, Cécile Cottet-Rousselle, Peggy Charbonnier, Christine Moriscot, Isabelle Michaud-Soret, Wojciech Bal, Alexandra Fuchs, et al.

    The impact on human health of the increasing use of silver nanoparticles (AgNPs) in medical devices remains understudied, even though AgNP-containing dressings are known to release silver in the bloodstream leading to accumulation and slow clearance in the liver. Cellular studies have shown the intracellular dissolution of AgNPs within endo-lysosomes followed by Ag(I) binding to biomolecular thiolate-containing molecules. However, the precise subcellular distribution of Ag(I) and the nature of the disrupted physiological pathways remained unknown. Novel imaging approaches enabled us to visualize the trafficking of AgNP-containing lysosomes towards a perinuclear location and a direct nuclear transfer of Ag(I) species with accumulation in the nucleoli. These Ag(I) species impaired nuclear receptor activity, disrupting critical mechanisms of liver physiology in very low dose exposure scenarios, thus justifying further research into defining a framework for the safe use of AgNPs.